Related Experiment Videos
Consent and long-term neuroleptic treatment
N R Harris1, K Lovell, J C Day
1School of Nursing, Midwifery and Health Visiting, University of Manchester, Manchester, UK.
Journal of Psychiatric and Mental Health Nursing
|August 8, 2002
Summary
Obtaining informed consent for schizophrenia patients requires genuine collaboration. Nurses face challenges with blurred professional boundaries when securing consent for neuroleptic medication, crucial for relapse prevention.
Area of Science:
- Psychiatry
- Nursing Practice
- Mental Health Care
Background:
- Client involvement in care planning is essential for effective treatment.
- Informed consent is a cornerstone of collaborative therapeutic relationships.
- Non-adherence to neuroleptic medication is a primary driver of relapse in schizophrenia.
Purpose of the Study:
- To review challenges in obtaining informed consent for schizophrenia patients.
- To examine the nurse's role in the informed consent process for this population.
- To explore issues arising from blurred professional boundaries in psychiatric nursing.
Main Methods:
- Literature review focusing on informed consent in schizophrenia treatment.
- Analysis of the nurse's role and professional boundary issues.
- Reference to UKCC guidelines for nursing practice.
Main Results:
- Securing informed consent for neuroleptic medication in schizophrenia is complex.
- Blurred professional boundaries can impede the informed consent process.
- Nurses must navigate ethical and practical challenges in this area.
Conclusions:
- Genuine collaboration is key to informed consent in schizophrenia care.
- Clear professional boundaries are vital for nurses facilitating informed consent.
- Adherence to UKCC standards supports ethical nursing practice.